HealthEquity, Inc. $HQY Stock Position Boosted by Moody Aldrich Partners LLC

Key Points

• Moody Aldrich Partners more than doubled its HealthEquity stake in the third quarter, increasing holdings by 116.8% to 48,967 shares valued at approximately $4.33 million. Institutional investors collectively own 99.55% of HQY.
• Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $113.53; Deutsche Bank recently raised its target to $142.
• HealthEquity exceeded quarterly expectations, reporting $1.24 in adjusted earnings per share and $350.73 million in revenue, up 95.5% year over year. Shares opened at $101.34, near the company’s 52-week high of $107.62.

Moody Aldrich Partners LLC grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 116.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 48,967 shares of the company's stock after acquiring an additional 26,377 shares during the period. Moody Aldrich Partners LLC owned about 0.06% of HealthEquity worth $4,332,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Leonteq Securities AG increased its holdings in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after purchasing an additional 235 shares during the period. Axiom Investment Management LLC bought a new position in HealthEquity during the 1st quarter worth $33,000. Silvant Capital Management LLC bought a new position in HealthEquity during the 2nd quarter worth $35,000. Public Employees Retirement System of Ohio acquired a new position in HealthEquity during the 2nd quarter worth about $39,000. Finally, International Assets Investment Management LLC lifted its holdings in HealthEquity by 18,333.3% during the 1st quarter. International Assets Investment Management LLC now owns 553 shares of the company's stock worth $46,000 after buying an additional 550 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Analyst Ratings Changes

A number of research firms have commented on HQY. BTIG Research reiterated a "buy" rating and issued a $115.00 price target on shares of HealthEquity in a research report on Friday, August 28th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Saturday, October 10th. Weiss Ratings raised HealthEquity from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $135.00 to $142.00 and gave the stock a "buy" rating in a research note on Monday, August 31st. Finally, Citigroup reiterated a "market outperform" rating on shares of HealthEquity in a report on Friday, August 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $113.53.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $101.34 on Thursday. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. The business has a 50-day moving average price of $95.46 and a two-hundred day moving average price of $88.91. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The company has a market cap of $8.38 billion, a P/E ratio of 36.58, a PEG ratio of 1.64 and a beta of 0.24.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The firm had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. The firm's revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 3.93 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company's offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.